All News

2021

December

Media Release / Dec 22, 2021

Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA

Read More
Media Release / Dec 20, 2021

Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA

Read More

October

Media Release / Oct 26, 2021

Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz

Read More
Media Release / Oct 21, 2021

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

Read More
Media Release / Oct 11, 2021

Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics

Read More
Media Release / Oct 01, 2021

Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs

Read More

September

Media Release / Sep 08, 2021

Sandoz strengthens pipeline by entering into agreement for biosimilar bevacizumab, a key oncology medicine

Read More

July

Media Release / Jul 21, 2021

Novartis delivered strong Q2 performance, driven by momentum of key growth brands. FY 2021 guidance unchanged.

Read More
Media Release / Jul 16, 2021

Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia

Read More

June

Media Release / Jun 25, 2021

Sandoz announces EU launch of ready-to-dilute generic Pemetrexed to treat most prevalent form of lung cancer

Read More